News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
648,098 Results
Type
Article (50823)
Company Profile (149)
Press Release (597116)
Multimedia
Podcasts (150)
Webinars (27)
Section
Business (181007)
Career Advice (1983)
Deals (29740)
Drug Delivery (127)
Drug Development (81811)
Employer Resources (124)
FDA (17043)
Job Trends (12904)
News (318045)
Policy (33295)
Tag
Academia (2475)
Academic (2)
Accelerated approval (25)
Adcomms (34)
Allergies (121)
Alliances (48062)
ALS (167)
Alzheimer's disease (1676)
Antibody-drug conjugate (ADC) (302)
Approvals (17163)
Artificial intelligence (499)
Autoimmune disease (119)
Automation (29)
Bankruptcy (262)
Best Places to Work (9997)
BIOSECURE Act (22)
Biosimilars (178)
Biotechnology (107)
Bladder cancer (147)
Brain cancer (58)
Breast cancer (567)
Cancer (4390)
Cardiovascular disease (380)
Career advice (1696)
Career pathing (35)
CAR-T (254)
CDC (38)
Cell therapy (685)
Cervical cancer (33)
Clinical research (69276)
Collaboration (1511)
Company closure (5)
Compensation (745)
Complete response letters (61)
COVID-19 (2597)
CRISPR (80)
C-suite (658)
Cystic fibrosis (140)
Data (5609)
Decentralized trials (2)
Denatured (49)
Depression (127)
Diabetes (469)
Diagnostics (5637)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (38)
Drug discovery (251)
Drug pricing (201)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (74987)
Editorial (57)
Employer branding (16)
Employer resources (112)
Events (98865)
Executive appointments (913)
FDA (19794)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (1276)
Gene editing (174)
Generative AI (48)
Gene therapy (546)
GLP-1 (1022)
Government (4547)
Grass and pollen (6)
Guidances (360)
Healthcare (16190)
HIV (51)
Huntington's disease (39)
IgA nephropathy (77)
Immunology and inflammation (246)
Immuno-oncology (34)
Indications (73)
Infectious disease (2821)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (93)
Intellectual property (208)
Interviews (361)
IPO (13436)
IRA (59)
Job creations (3276)
Job search strategy (1421)
Kidney cancer (16)
Labor market (62)
Layoffs (549)
Leadership (31)
Legal (7632)
Liver cancer (89)
Longevity (10)
Lung cancer (614)
Lymphoma (352)
Machine learning (37)
Management (41)
Manufacturing (665)
MASH (158)
Medical device (11165)
Medtech (11196)
Mergers & acquisitions (17217)
Metabolic disorders (1217)
Multiple sclerosis (146)
NASH (20)
Neurodegenerative disease (308)
Neuropsychiatric disorders (81)
Neuroscience (2819)
NextGen: Class of 2025 (5475)
Non-profit (3913)
Now hiring (33)
Obesity (585)
Opinion (313)
Ovarian cancer (142)
Pain (170)
Pancreatic cancer (180)
Parkinson's disease (261)
Partnered (25)
Patents (426)
Patient recruitment (376)
Peanut (49)
People (53177)
Pharmaceutical (37)
Pharmacy benefit managers (29)
Phase I (21161)
Phase II (29963)
Phase III (23283)
Pipeline (3669)
Policy (296)
Postmarket research (3134)
Preclinical (9145)
Press Release (67)
Prostate cancer (220)
Psychedelics (50)
Radiopharmaceuticals (261)
Rare diseases (742)
Real estate (4927)
Recruiting (50)
Regulatory (25072)
Reports (35)
Research institute (2323)
Resumes & cover letters (299)
Rett syndrome (24)
RNA editing (11)
RSV (60)
Schizophrenia (143)
Series A (214)
Series B (153)
Service/supplier (9)
Sickle cell disease (91)
Special edition (23)
Spinal muscular atrophy (167)
Sponsored (38)
Startups (3249)
State (2)
Stomach cancer (18)
Supply chain (95)
Tariffs (91)
The Weekly (99)
Vaccines (908)
Venture capital (64)
Weight loss (408)
Women's health (63)
Worklife (15)
Date
Today (41)
Last 7 days (572)
Last 30 days (2210)
Last 365 days (29605)
2025 (28802)
2024 (32883)
2023 (36576)
2022 (47126)
2021 (50262)
2020 (48075)
2019 (41003)
2018 (31067)
2017 (30362)
2016 (29511)
2015 (33906)
2014 (27838)
2013 (23896)
2012 (25069)
2011 (25505)
2010 (24302)
Location
Africa (840)
Alabama (82)
Alaska (6)
Arizona (200)
Arkansas (13)
Asia (43214)
Australia (6874)
California (9548)
Canada (2833)
China (1008)
Colorado (383)
Connecticut (434)
Delaware (301)
Europe (90553)
Florida (1415)
Georgia (305)
Hawaii (2)
Idaho (43)
Illinois (727)
India (60)
Indiana (442)
Iowa (20)
Japan (369)
Kansas (116)
Kentucky (34)
Louisiana (20)
Maine (44)
Maryland (1242)
Massachusetts (7050)
Michigan (270)
Minnesota (484)
Mississippi (4)
Missouri (105)
Montana (26)
Nebraska (23)
Nevada (103)
New Hampshire (56)
New Jersey (2735)
New Mexico (27)
New York (2622)
North Carolina (1300)
North Dakota (10)
Northern California (4532)
Ohio (267)
Oklahoma (21)
Oregon (33)
Pennsylvania (1897)
Puerto Rico (16)
Rhode Island (45)
South America (1101)
South Carolina (40)
South Dakota (1)
Southern California (3768)
Tennessee (145)
Texas (1496)
United States (34478)
Utah (274)
Vermont (1)
Virginia (236)
Washington D.C. (78)
Washington State (828)
West Virginia (3)
Wisconsin (99)
Wyoming (2)
648,098 Results for "hunan tigermed xiangya drug r and d ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
October 17, 2025
·
3 min read
Rare diseases
Biohaven Cuts R&D Spending by 60% After FDA Rejection of Drug for Rare Neurodegenerative Disease
Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to the progressive loss of control over movement.
November 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tigermed Completes Acquisition of Japanese CRO Micron
July 29, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea
November 6, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses
Company Is Advancing Use of Novel Doxorubicin-containing Microneedle Array (D-MNA) Patch in Veterinary Oncology as an Orphan Drug
June 9, 2025
·
10 min read
Labor market
Massachusetts R&D, Biomanufacturing Jobs Fell in ’24: Report
Massachusetts biopharma workforce growth was fairly flat last year, and R&D and manufacturing employment declined, according to a new MassBio report.
BioSpace
data further highlight challenges facing the state, showing roughly 2,300 people out of work in 2025 and jobs live on the website falling.
August 27, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Tigermed Reports Full Year 2024 Results
March 28, 2025
·
9 min read
Layoffs
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees
Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.
September 11, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
September 30, 2025
·
10 min read
Press Releases
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
October 31, 2025
·
8 min read
1 of 64,810
Next
